Clinical Trials
1
Active:0
Completed:1
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Evaluating the Efficacy of Artificial Intelligence-based Computer Aided Diagnosis Software That Assists in Determining Whether or Not to Conduct Amyloid PET for the Diagnosis of Alzheimer's Disease by Predicting Amyloid PET Positivity in Mild Cognitive Impairment Patients
Completed
- Conditions
- Alzheimer DiseaseMild Cognitive Impairment
- First Posted Date
- 2022-05-19
- Last Posted Date
- 2022-09-16
- Lead Sponsor
- Neurozen Inc.
- Target Recruit Count
- 227
- Registration Number
- NCT05383053
- Locations
- 🇰🇷
Chonnam National University Hospital, Gwangju, Korea, Republic of
News
No news found